LifeScience Biologics

Liminal BioSciences Announces Discontinuation of Fezagepras Development

The decision to discontinue the development of fezagepras is based on results from the Phase 1a single ascending dose ("SAD") clinical trial, which indicat...

 July 22, 2022 | News

Navigo Proteins Successfully Develops Affinity Resin Against Ferritin for Blood Fraction Processing

(“Navigo”), a premier protein engineering company and developer of affinity ligands for custom chromatography solutions, today announces succes...

 July 21, 2022 | News

Brii Bio Announces Strategic Partnership with China Resources Pharmaceutical Commercial Group

The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China The ...

 July 20, 2022 | News

Sobi to license loncastuximab tesirine from ADC Therapeutics

Sobi® announced an exclusive license agreement with ADC Therapeutics SA to develop and commercialise loncastuximab tesirine for use in haematology and ...

 July 11, 2022 | News

WuXi XDC and AbTis Sign Memorandum of Understanding for Development and Manufacturing of Antibody Drug Conjugates

Under the partnership, AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing, ADC conjugation process developm...

 July 08, 2022 | News

Enosi Therapeutics Partners with Danuo Science Group to Accelerate Multiple Therapeutic Programs

Enosi Therapeutics, a Delaware Corporation, focused on providing industry-leading therapeutics for cancer and autoimmune diseases, has announced a partners...

 July 06, 2022 | News

AI Drives Data Insights for Doctors and their Patients

Dr. Lina Basel-Salmon has been treating rare disease patients at Schneider Children’s Medical Center of Israel and Beilinson Hospital at th...

 July 04, 2022 | News

Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology

“This collaboration with Twist moves us closer to our vision of becoming a fully global healthcare company while also continuing to drive novel thera...

 July 01, 2022 | News

BGI Group Continues To Lead In Life Sciences 22 Years After The Human Genome Project

BGI was formed to be a part of the HGP, contributing to the sequencing of genes and working alongside scientists from six countries. Twenty-two years ago t...

 June 28, 2022 | News

IFN Neurologic and MetaCell Partner to Launch the IFN Neurologic Affiliate Program

This application will help clinicians to better serve patients with neurological disorders and provide treatments in the functional neuroscience domain. Th...

 June 28, 2022 | News

Sanofi Enters into a Partnering Agreement with Health2Sync

Sanofi K.K. (Head office: Shinjuku-ku, Tokyo; President: Takahiko Iwaya; hereinafter "Sanofi") and Health2Sync. (Head office: Taito-ku, Toky...

 June 28, 2022 | News

SNIA Announces DNA Data Storage Technology Affiliate

The Storage Networking Industry Association (SNIA) takes another leap forward in the industry today by enabling technical work and standards development fo...

 June 24, 2022 | News

Biocon Biologics issues a statement in response to the media reports related to bribery allegations.

Biocon Biologics is Governed by a Strong Code of Conduct   We strongly condemn any acts of corruption and violation of rules by way of offering or p...

 June 22, 2022 | News

Scientists take the first step to master an all-powerful cell type in the beginning of life

From cloning to regeneration, how to find alternative paths to create or rejuvenate life has been one of the big questions for biologists. It is this quest...

 June 22, 2022 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close